Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Clostridioides difficile infection (CDI) (recurrent) continues to pose a significant public health challenge, even with recent advancements. The response rates to currently approved antibiotic therapies are still inadequate. While treatments based on microbiota show promise, there is a need for thorough clinical trials to refine dosing strategies and confirm their long-term safety (1)
A prospective, randomized, double-blind, placebo-controlled phase II treatment trial evaluating RBX2660 vs placebo in adults with Clostridioides difficile infection (CDI) (recurrent) (2 or more …